The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

- The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

On Wednesday, Sonnet’s stock saw a dramatic rise, making it one of the most talked-about biotech stocks of the day. This uptick comes in the wake of a key announcement from the company: the issuance ...

We put 13 top models to the test — discover which one torched the competition thanks to its affordability, versatility and effectiveness.

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...

Promising initial Phase 1 data of EO-3021 reported in August highlighting 42.8% confirmed ORR observed in Claudin 18.2-enrich ...

Lisa George bid farewell to Coronation Street this past August after 13 years on the show. She spoke on BBC Morning Live ...

While the accident saw Lisa go partially blind in one eye, sight in the other has since deteriorated from 20/20 vision to ...

Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the third ...